The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Unapproved Peptides Lack Safety Data, Regulatory Incentives Misaligned Matt Kaeberlein posted on the topic LinkedIn RFK Jr. promotes peptides. Now the FDA weighs easing limits on the unproven chemicals In 2026, the question "Are peptides legal?" has been answered with a decisive regulatory crackdown. , The FDA has moved beyond general oversight into targeted enforcement. Popular wellness In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for